Valuation: Maccura Biotechnology Co.Ltd

Capitalization	6.2B 911M 783M 716M 680M 1.25B 87.79B 1.27B 8.57B 3.32B 41.54B 3.42B 3.35B 145B	P/E ratio 2026 *	64.1x	P/E ratio 2027 *	21.8x
Enterprise value	6.2B 911M 783M 716M 680M 1.25B 87.79B 1.27B 8.57B 3.32B 41.54B 3.42B 3.35B 145B	EV / Sales 2026 *	2.82x	EV / Sales 2027 *	2.29x
Free-Float	61.34%	Yield 2026 *	2.14%	Yield 2027 *	2.83%

* Estimated data More valuation ratios

Chart: Maccura Biotechnology Co.Ltd

Timeframe

Style

Dynamic Chart

Latest news : Maccura Biotechnology Co.Ltd

04-28	Maccura Biotechnology Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-28	Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-09	China Provincial Regulators Approve Maccura Biotechnology's Blood Gas, Biochemistry Testing System	MT
03-23	Maccura Biotechnology Co.Ltd(XSEC:300463) dropped from FTSE All-World Index	CI
01-02	Maccura Biotechnology Gets China Certification for Three Testing Kits	MT
24/10/25	Maccura Biotechnology Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
12/10/25	Han Siguang completed the acquisition of 51% stake in Shandong Maccura Biotechnology Co., Ltd. from Maccura Biotechnology Co.Ltd.	CI
31/07/25	Maccura Biotechnology Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI
11/07/25	Maccura Biotechnology Gets Registration Approvals for Four Diagnostic Kits	MT
11/06/25	Han Siguang signed a letter of intent to acquire 51% stake in Shandong Maccura Biotechnology Co., Ltd. from Maccura Biotechnology Co.Ltd for CNY 17.41 million.	CI
11/06/25	Maccura Biotechnology Gets Registration Certificates for Four Devices	MT
20/05/25	Maccura Biotechnology Co.Ltd Approves Final Cash Dividend on A Shares for the Year 2024, Payable on 28 May 2025	CI
29/04/25	Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2024	CI

More news

Managers and Directors: Maccura Biotechnology Co.Ltd

Manager	Title	Age	Since
Ming Jian Wu CEO	Chief Executive Officer	51	21/06/2017
Shan Yin DFI	Director of Finance/CFO	46	25/10/2021
Wen Jun Zhang IRC	Investor Relations Contact	-	-

Director	Title	Age	Since
Yong Tang CHM	Chairman	62	20/10/1994
Qi Lin Liu BRD	Director/Board Member	60	21/11/2009
Deng Ming Wang BRD	Director/Board Member	62	21/11/2009

More insiders

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MACCURA BIOTECHNOLOGY CO.LTD	-0.77%	-4.29%	-15.00%	-39.47%	919M
GUARDANT HEALTH, INC.	+0.11%	-2.26%	+134.90%	+220.21%	12.59B
BIOMÉRIEUX	+0.42%	+0.14%	-39.94%	-27.63%	9.82B
LANTHEUS HOLDINGS, INC.	-1.04%	-1.38%	+18.56%	-3.38%	6.11B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.68%	+3.88%	-10.76%	-12.33%	5.91B
ANDON HEALTH CO., LTD.	-1.26%	-3.53%	+84.99%	+82.05%	4.57B
DIASORIN S.P.A.	+0.03%	+5.67%	-24.99%	-30.63%	4.34B
CARIS LIFE SCIENCES, INC.	+3.95%	-5.58%	-	-	4.11B
AUTOBIO DIAGNOSTICS CO., LTD.	-0.27%	-1.79%	-14.82%	-42.82%	2.82B
10X GENOMICS, INC.	+1.70%	+4.63%	+140.20%	-61.01%	2.69B
Average	-0.07%	-1.04%	+30.35%	+9.44%	5.39B
Weighted average by Cap.	-0.14%	-0.34%	+39.33%	+46.77%

See all sector performances

Maccura Biotechnology Co Ltd is a China-based company mainly engaged in the research and development, production, sales and related services of in vitro diagnostic products. The Company mainly provides biochemical products, immunological products, molecular diagnostic products, clinical testing products, rapid testing platforms, pathology product platforms, and medical laboratory automation solutions. In vitro diagnostic products are divided into instruments and reagents by product category, and can be divided into biochemical, immunological, blood and body fluid, molecular, microbiological, pathological, rapid test and others by detection method. The Company mainly conducts its business in domestic and overseas markets.

Employees

3,472

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
17/05/26	10.26 ¥	-0.77%	6,027,610
15/05/26	10.34 ¥	-1.62%	9,467,768
14/05/26	10.51 ¥	-2.32%	7,898,977
13/05/26	10.76 ¥	-0.83%	7,057,504
12/05/26	10.85 ¥	-3.30%	12,096,000

End-of-day quote Shenzhen S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.26CNY

Average target price

12.30CNY

Spread / Average Target

+19.88%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Shenzhen S.E. Other stock markets 18/05/2026			5-day change	1st Jan Change
10.26 ^CNY	-0.77%		-4.29%	-8.31%

1 day	-0.77%
1 week	-4.29%
Current month	-2.19%
1 month	-3.66%
3 months	-12.23%
6 months	-14.78%
Current year	-8.31%

1 week	10.16	11.12
1 month	10.16	11.34
Current year	10.16	14.2
1 year	10.16	14.2
3 years	9.9	17.4
5 years	9.9	49.34
10 years	9.9	65.24

	2026 *	2027 *
Net sales	2.2B 324M 278M 254M 242M 445M 31.17B 452M 3.04B 1.18B 14.75B 1.21B 1.19B 51.41B	2.71B 399M 343M 313M 298M 548M 38.4B 557M 3.75B 1.45B 18.17B 1.5B 1.46B 63.34B
Net income	94.15M 13.83M 11.88M 10.87M 10.32M 19.01M 1.33B 19.34M 130M 50.43M 630M 51.9M 50.8M 2.2B	284M 41.75M 35.87M 32.82M 31.17M 57.39M 4.02B 58.37M 393M 152M 1.9B 157M 153M 6.63B
Net Debt	-	-

Maccura Biotechnology Co.Ltd Share Price

Equities

300463

CNE1000020H3